- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05127993
Comprehensive Evaluation of the Passive Talaris Demonstrator
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Twenty-eight healthy active participants with an unilateral transtibial amputation will conduct 2 experimental trials (EXP1 & EXP2) on the same day in a randomized order, i.e. EXP1 with the currently used prosthesis and EXP2 with the passive Talaris Demonstrator. Each experimental trial will include 6 minutes of treadmill walking at 3 different speeds in consecutive blocks of 2 minutes, a slope walking test, a stair climbing test, a L-test and an outdoor walking task.
The six minutes walk test (6MWT) has become one of the most widely used performance-based outcome measures of functional mobility and exercise capacity. Recently, the 6MWT has been found to correlate with single-limb balance time and symmetry of step length in people with amputation. Additionally, the 6MWT distance has been shown to be responsive to functional training interventions in people with lower-limb amputation. Six minutes of treadmill walking at 3 different speeds will be performed. This test will be performed in consecutive blocks of 2 minutes. These consecutive blocks will be walking 2 minutes at self-selected (SS) speed, 2 minutes at 75% of the SS speed and 2 minutes at 125% of the SS speed. These different walking speeds elicit different angular positions of the ankle and activation levels of muscles, and thus might alter the effectiveness of the novel device.
The slope walking test assesses the participants' ability to ascend and descend a 6 m long ramp of 10% inclination as fast as possible. For safety reasons bilateral handrails are warranted. Participants start the test in an upright position in front of the ramp and are asked to ascend the ramp, turn around on the platform, descend the ramp and return to the starting position.
The stair climbing test assesses the participants' ability to ascend and descend a staircase (84 cm total height, 3-step staircase with an average rise of 28 cm and run of 18 cm). Participants start in front of the staircase and are asked to ascend and descend as fast as possible. Again, bilateral handrails are required to allow support when needed. The ascending phase is initiated with the prosthetic side, while the first step of the descending phase is performed with the non-involved leg.
The L-test, requires higher physical activity of the user. During the L-test, participants are asked to rise from a chair, walk 7 meters, turn 90 degrees, walk 3 meters, turn 180 degrees and then return in the same way to the seated position. A total distance of 20 meter is covered.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Brussels, Bélgica, 1050
- Vrije Universiteit Brussel
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Unilateral transtibial (below knee) amputation
- Unilateral transfemoral (above knee) amputation
- Healthy subject
- Medicare Functional Classification Level: K2-4
Exclusion Criteria:
- Any neurological disease
- Upper limb or bilateral amputation
- Stump pain or bad fit of the socket
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Ciencia básica
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Novel prosthesis
A unilateral transtibial amputee will conduct experiments with the novel prosthesis followed by experiments with the current prosthesis.
|
The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by "Axiles Bionics".
|
|
Comparador activo: Current prosthesis
A unilateral transtibial amputee will conduct experiments with the current prosthesis followed by experiments with the novel prosthesis.
|
The amputee will walk with the passive Talaris Demonstrator, a novel prosthetic foot, designed and built by "Axiles Bionics".
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Performance
Periodo de tiempo: Through study completion, a period of 4 months
|
Heart rate during all tasks
|
Through study completion, a period of 4 months
|
|
Performance
Periodo de tiempo: Through study completion, a period of 4 months
|
Time needed to perform the L-test
|
Through study completion, a period of 4 months
|
|
Performance
Periodo de tiempo: Through study completion, a period of 4 months
|
Speed during 6 minutes walk test
|
Through study completion, a period of 4 months
|
|
Physiological
Periodo de tiempo: Through study completion, a period of 4 months
|
Electromyography: lower limb muscle activity during different movements (% of the MVC)
|
Through study completion, a period of 4 months
|
|
Physiological
Periodo de tiempo: Through study completion, a period of 4 months
|
Oxygen consumption during stair climbing, slope walking and during the 6 minutes walk test
|
Through study completion, a period of 4 months
|
|
Psychological
Periodo de tiempo: Through study completion, a period of 4 months
|
Visual analogue scale for comfort (score: 0= not comfortable, 100 = comfortable) and fatigue (score: 0= not fatiguing, 100 = fatiguing) during all tasks
|
Through study completion, a period of 4 months
|
|
Biomechanical
Periodo de tiempo: Through study completion, a period of 4 months
|
Joint angels and joint angular velocities of hip, knee and ankle joints
|
Through study completion, a period of 4 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Kevin De Pauw, Vrije Universiteit Brussel
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- BUN143201526629
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .